A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infectionTarek Hassanein, David Gardiner, Eric Lawitz et al.|Journal of Hepatology|2015Cited by 53
Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeksScott Fung, Marı́a Buti, Calvin Q. Pan et al.|Alimentary Pharmacology & Therapeutics|2023Cited by 14